Diadema Partners’s Edesa Biotech EDSA Stock Holding History

Diadema Partners’s Portfolio EDSA Stock Details EDSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-54,025	Closed	-$76.7K	–	164
2025 Q4	$76.7K	Buy	+54,025	New	+$106K	0.01%	138

Other funds holding EDSA

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

SRL

Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return

Diadema Partners's EDSA Position: Q1 2026 in Review

Diadema Partners sold out of Edesa Biotech (EDSA) in Q1 2026, closing a stake of 54,025 shares — an estimated $76.7K sold.

Diadema Partners first reported a position in EDSA in Q4 2025 and held it in 1 quarter. The position peaked at $76.7K in Q4 2025. 28 funds tracked by Wall St. Rank hold EDSA as of Q1 2026.

Diadema Partners reported no remaining Edesa Biotech position as of Q1 2026 after selling out during the quarter.
Diadema Partners sold 54,025 Edesa Biotech shares in Q1 2026, an estimated $76.7K.
Diadema Partners first reported a position in Edesa Biotech in Q4 2025 and held it in 1 quarter.
Diadema Partners's Edesa Biotech position peaked at $76.7K in Q4 2025.
28 funds tracked by Wall St. Rank held Edesa Biotech as of Q1 2026.

Based on Diadema Partners's 13F filing for Q1 2026, filed 15 May 2026.